Related references
Note: Only part of the references are listed.The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
Elodie E. Noel et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Expression of EGFR, HER-2/neu and KIT in germ cell tumours
Ignacio Duran et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin
James E. Korkola et al.
BJU INTERNATIONAL (2009)
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
PM Voorhoeve et al.
CELL (2006)
Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours
A di Pietro et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma
JS Kerley-Hamilton et al.
ONCOGENE (2005)
Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells
M Bai et al.
MODERN PATHOLOGY (2004)
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors
F Mayer et al.
ANNALS OF ONCOLOGY (2003)
p27 and cyclin E/D2 associations in testicular germ cell tumors - Implications for tumorigenesis
R Kukoski et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2003)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Role of P53 and MDM2 in treatment response of human germ cell tumors
AMF Kersemaekers et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)